<DOC>
	<DOCNO>NCT01331993</DOCNO>
	<brief_summary>The primary purpose demonstrate bioequivalence naproxen administer VIMOVO manufacture new facility Sweden ( AstraZeneca ) naproxen administer VIMOVO manufacture USA ( Patheon ) market enteric-coated naproxen formulation .</brief_summary>
	<brief_title>A Bioequivalence Study Compare VIMOVO Manufactured AstraZenca AB VIMOVO Manufactured Patheon Pharmaceuticals Marketed Enteric-coated Naproxen Formulation</brief_title>
	<detailed_description>A Phase I , Open-label , Randomised , 3-way Crossover Study demonstrate Bioequivalence Single Oral Dose Naproxen administer VIMOVO manufacture AstraZeneca AB compare VIMOVO manufacture Patheon Pharmaceuticals market enteric-coated Naproxen Formulation ( Manufactured Roche ) Healthy Volunteers .</detailed_description>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy male female volunteer , age 18 55 year ( inclusive ) Female volunteer must nonpregnant nonlactating negative urine pregnancy test result prior enrolment study . Female volunteer childbearing potential must use appropriate birth control entire duration study Body mass index = 19 =30 kg/m2 ( inclusive ) weight = 50 = 100 kg ( inclusive ) Volunteer likely unrecognized cardiovascular cerebrovascular disease , base history risk factor , clinical significant ECG find screen Uncontrolled hypertension define rest systolic pressure &gt; 140 mmHg diastolic pressure &gt; 90 mmHg screen admission Period 1 Presence prior history abnormal bleeding bleeding disorder , volunteer significant history peptic ulcer disease acid related gastrointestinal symptom Any gastrointestinal disease , abnormality gastric surgery may interfere gastric emptying , motility drug absorption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>crossover</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>naproxen</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>vimovo</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>